Analysis of Transplant-Eligible Patients (Pts) Who Received Frontline Daratumumab (DARA)-Based Quadruplet Therapy for the Treatment of Newly Diagnosed Multiple Myeloma (NDMM) with High-Risk Cytogenetic Abnormalities (HRCA) in the Griffin and Master Studies

被引：18

作者：

Callander, Natalie ^{[1
]}

Silbermann, Rebecca ^{[2
]}

Kaufman, Jonathan L. ^{[3
]}

Godby, Kelly N. ^{[4
]}

Laubach, Jacob P. ^{[5
]}

Schmidt, Timothy Martin ^{[1
]}

Sborov, Douglas W. ^{[6
]}

Medvedova, Eva ^{[2
]}

Reeves, Brandi ^{[7
]}

Dhakal, Binod ^{[8
]}

Rodriguez, Cesar ^{[9
]}

Chhabra, Saurabh ^{[1
]}

Chari, Ajai ^{[10
]}

Bal, Susan ^{[11
]}

Anderson, Larry D., Jr. ^{[12
]}

Dholaria, Bhagirathbhai ^{[13
]}

Nathwani, Nitya ^{[14
]}

Hari, Parameswaran ^{[15
]}

Shah, Nina ^{[16
]}

Bumma, Naresh ^{[17
]}

Holstein, Sarah A. ^{[18
]}

Costello, Caitlin ^{[19
]}

Jakubowiak, Andrzej ^{[20
]}

Wildes, Tanya M. ^{[18
]}

Orlowski, Robert Z. ^{[21
]}

Shain, Ken H. ^{[22
]}

Cowan, Andrew J. ^{[23
]}

Pei, Huiling ^{[24
]}

Cortoos, Annelore ^{[25
]}

Patel, Sharmila ^{[25
]}

Lin, Thomas S. ^{[25
]}

Giri, Smith ^{[26
]}

Costa, Luciano J. ^{[27
]}

Richardson, Paul G. ^{[28
]}

Usmani, Saad ^{[29
]}

Voorhees, Peter M. ^{[30
]}

机构：

[1] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[3] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA

[4] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham Hosp, Birmingham, AL USA

[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[7] Univ N Carolina, Chapel Hill, NC 27515 USA

[8] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA

[9] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[10] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[11] Univ Alabama Birmingham, Birmingham Hosp, Birmingham, AL USA

[12] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Myeloma Waldenstroms & Amyloidosis Program, Dallas, TX USA

[13] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA

[14] City Hope Comprehens Canc Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Duarte, CA USA

[15] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[16] Univ Calif San Francisco, San Francisco, CA 94143 USA

[17] Ohio State Univ, Div Hematol, Comprehens Canc Ctr, Columbus, OH USA

[18] Univ Nebraska Med Ctr, Dept Internal Med, Div Oncol & Hematol, Omaha, NE USA

[19] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA

[20] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA

[21] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[22] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[23] Univ Washington, Div Med Oncol, Seattle, WA USA

[24] Janssen Res & Dev LLC, Titusville, NJ USA

[25] Janssen Sci Affairs LLC, Horsham, PA USA

[26] UAB Sch Med Hematol & Oncol, Birmingham, AL USA

[27] Univ Alabama, Birmingham Hosp, Vestavia, AL USA

[28] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[29] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[30] Atrium Hlth Wake Forest Baptist, Levine Canc Inst, Charlotte, NC USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160451

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10144 / 10147

页数：4